25000 GSK Jan 43 calls over Jan 37 puts went up in 2 blocks on the PHLX marked buy write
Shares of GlaxoSmithKline plc (GSK) are down .16 to 40.22. GSK is near the middle of the 52 week range.
- Paper traded 25000 GSK Jan 43 calls over Jan 37 puts for .80 and .70.
- The ADV is 3016 contracts.?
- The OI is just over 1000 contracts.
The volume went up in 2 blocks on the PHLX marked buy write. ?A block of stock on 1.25 million shares trade concurrent with the combination.? As priced the trade is long the 43 strike and short the 37 strike so any big move up or drop to the mid-30s will make this trade work.
- IV 30 is trading 26%.?
- HV10 is trading for 14%.?
- IV 30 is trading above the HV 10.
GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK’s Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines.